We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 53.92%
This Fund
S&P 500
This Quarter Est. Return
+18.65%
1 Year Est. Return
+53.92%
3 Year Est. Return
+208.37%
5 Year Est. Return
+342.22%
10 Year Est. Return
+3,246.09%
AUM
$2.55B
AUM Growth
+$253M
Cap. Flow
-$30.3M
Cap. Flow %
-1.19%
Top 10 Hldgs %
26.33%
Holding
389
New
55
Increased
83
Reduced
93
Closed
46

Sector Composition

Rank Sector Weight
1 Technology 29.39%
2 Healthcare 17.89%
3 Consumer Discretionary 15.15%
4 Industrials 9.02%
5 Financials 8.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVS icon
26
Las Vegas Sands
LVS
$32.2B
$27M 1.06%
578,924
+164,390
+40% +$7.86M
XLB icon
27
State Street Materials Select Sector SPDR ETF
XLB
$8.72B
$26M 1.02%
+816,000
New +$25.3M
DXCM icon
28
DexCom
DXCM
$29B
$25.4M 1%
246,840
-38,300
-13% -$4M
KSU
29
DELISTED
Kansas City Southern
KSU
$25.3M 0.99%
139,950
-11,880
-8% -$2.06M
ORLY icon
30
O'Reilly Automotive
ORLY
$75.1B
$22.8M 0.9%
743,115
-63,150
-8% -$1.92M
LULU icon
31
lululemon athletica
LULU
$13.5B
$21.7M 0.85%
65,953
-4,110
-6% -$1.37M
NUAN
32
DELISTED
Nuance Communications, Inc.
NUAN
$21.1M 0.83%
637,050
-97,485
-13% -$2.83M
TSLA icon
33
Tesla
TSLA
$1.18T
$20.4M 0.8%
142,380
+38,160
+37% +$4.51M
HZNP
34
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$19.9M 0.78%
256,585
-92,000
-26% -$6.33M
UNH icon
35
UnitedHealth
UNH
$382B
$18.6M 0.73%
59,680
-26,040
-30% -$8M
EW icon
36
Edwards Lifesciences
EW
$49.4B
$18.2M 0.71%
227,930
+27,520
+14% +$2.15M
SPLK
37
DELISTED
Splunk Inc
SPLK
$17.2M 0.67%
91,510
-7,670
-8% -$1.53M
NTRA icon
38
Natera
NTRA
$36.4B
$16.6M 0.65%
230,079
-806
-0.3% -$45.8K
MSCI icon
39
MSCI
MSCI
$42.4B
$16.4M 0.64%
46,075
-4,090
-8% -$1.48M
ENPH icon
40
Enphase Energy
ENPH
$4.62B
$16.1M 0.63%
194,924
+48,719
+33% +$3.26M
HALO icon
41
Halozyme
HALO
$9.88B
$15.7M 0.62%
598,617
+37,432
+7% +$1.04M
TNDM icon
42
Tandem Diabetes Care
TNDM
$1.27B
$15M 0.59%
131,850
+30,065
+30% +$3.16M
AXNX
43
DELISTED
Axonics, Inc. Common Stock
AXNX
$14M 0.55%
274,564
+51,742
+23% +$2.16M
LPSN icon
44
LivePerson
LPSN
$22M
$13.8M 0.54%
17,643
+4,092
+30% +$3.07M
GDOT icon
45
Green Dot
GDOT
$750M
$13.3M 0.52%
263,453
+41,548
+19% +$2.13M
VRNS icon
46
Varonis Systems
VRNS
$4.67B
$13.1M 0.51%
339,723
-190,986
-36% -$7.12M
MNTV
47
DELISTED
Momentive Global Inc. Common Stock
MNTV
$13M 0.51%
586,875
+20,432
+4% +$475K
LLY icon
48
Eli Lilly
LLY
$1.08T
$12.6M 0.49%
+84,860
New +$13.1M
MYOK
49
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$12.5M 0.49%
92,031
+21,005
+30% +$2.23M
HELE icon
50
Helen of Troy
HELE
$656M
$12.5M 0.49%
64,566
-8,564
-12% -$1.7M

Similar funds

Castleark Management's Q3 2020 Portfolio in Review

As of Q3 2020, Castleark Management held 389 positions worth $2.55B, up 11% from $2.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Castleark Management's Q3 2020 filing shows 55 new, 83 increased, 93 reduced and 46 closed positions. Its largest new stake was State Street Materials Select Sector SPDR ETF: 816,000 shares worth $26M. The largest sale was Alphabet (Google) Class C, an estimated $69.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Castleark Management's largest Q3 2020 buy was State Street Materials Select Sector SPDR ETF: 816,000 shares worth $26M.
  • Castleark Management added most to Meta Platforms (Facebook) in Q3 2020, an estimated $54M increase.
  • Castleark Management's biggest Q3 2020 reduction was Alphabet (Google) Class C, cutting an estimated $69.7M.
  • Castleark Management fully exited ZYNGA INC. CL A COMMON in Q3 2020, selling an estimated $11M.
  • Castleark Management's ten largest holdings make up 26% of its $2.55B portfolio in Q3 2020.
  • Castleark Management opened 55 new positions and closed 46 in Q3 2020.
  • Castleark Management's portfolio value rose 11% quarter-over-quarter to $2.55B.

Based on Castleark Management's 13F filing for Q3 2020, filed 16 Nov 2020.